Your browser doesn't support javascript.
loading
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer.
Lee, Jin Sun; Yost, Susan E; Blanchard, Suzette; Schmolze, Daniel; Yin, Hongwei Holly; Pillai, Raju; Robinson, Kim; Tang, Aileen; Martinez, Norma; Portnow, Jana; Wen, Wei; Yim, John H; Brauer, Heather Ann; Ren, Yuqi; Luu, Thehang; Mortimer, Joanne; Yuan, Yuan.
Afiliación
  • Lee JS; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Yost SE; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Blanchard S; Department of Biostatistics, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Schmolze D; Department of Pathology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Yin HH; Department of Pathology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Pillai R; Department of Pathology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Robinson K; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Tang A; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Martinez N; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Portnow J; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.
  • Wen W; Department of Surgery, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Yim JH; Department of Surgery, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
  • Brauer HA; NanoString Technologies, Inc., Seattle, WA, USA.
  • Ren Y; NanoString Technologies, Inc., Seattle, WA, USA.
  • Luu T; OncoGambit, Irvine, CA, USA.
  • Mortimer J; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. jmortimer@coh.org.
  • Yuan Y; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. yuyuan@coh.org.
Breast Cancer Res ; 21(1): 119, 2019 11 08.
Article en En | MEDLINE | ID: mdl-31703728
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Regulación Neoplásica de la Expresión Génica / Perfilación de la Expresión Génica / Neoplasias de la Mama Triple Negativas Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Regulación Neoplásica de la Expresión Génica / Perfilación de la Expresión Génica / Neoplasias de la Mama Triple Negativas Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos